ArticleOpen forum infectious diseases2022

Model-Based Efficacy and Toxicity Comparisons of Moxifloxacin for Multidrug-Resistant Tuberculosis.

Hwi-Yeol Yun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.